Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (HCV)

被引：0
|
作者：
McCombs, Jeffrey S.
Shin, Janet
Hines, Patricia
Saab, Sammy
Yuan, Yong
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S936 / S936
页数：1
相关论文
共 50 条
  • [21] Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection - A Real-World Cohort Study
    Luo, Yang
    Zhang, Yue
    Wang, Di
    Shen, Di
    Che, Yi-Qun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5323 - 5330
  • [22] TRIPLE THERAPY FOR HEPATITIS C VIRUS (HCV) INFECTION IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS: LESSONS LEARNED FROM THE FIRST REAL-WORLD EXPERIENCE
    Maasoumy, B.
    Port, K.
    Markova, A. A.
    Serrano, B. Calle
    Sollik, L.
    Kirschner, J.
    Mix, C.
    Manns, M. P.
    Wedemeyer, H.
    Cornberg, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S351 - S351
  • [23] Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment
    Janjua, Naveed
    Wilton, James
    Cook, Darrel
    Wong, Stanley
    Butt, Zahid
    Bartlett, Sofia
    Pearce, Margo
    Ramji, Alnoor
    Yoshida, Eric
    Yu, Amanda
    Alvarez, Maria
    Binka, Mawuena
    Krajden, Mel
    JOURNAL OF HEPATOLOGY, 2020, 73 : S356 - S357
  • [24] real-world outcomes of hepatitis C treatment in thai patients
    Thanak, Pongpan
    Kitiyakara, Taya
    Intaraprasong, Pongphob
    Sobhonslidsuk, Abhasnee
    Achalanan, Narin
    Kamalaporn, Patarapong
    Kositchaiwat, Chomsri
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 247 - 247
  • [25] REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT
    Krajden, Mel
    Cook, Darrel
    Wong, Stanley
    Wilton, James
    Butt, Zahid Ahmad
    Bartlett, Sofia
    Pearce, Margo
    Ramji, Alnoor
    Yoshida, Eric M.
    Yu, Amanda
    Alvarez, Maria Jose
    Binka, Mawuena
    Janjua, Naveed
    HEPATOLOGY, 2019, 70 : 914A - 914A
  • [26] Predictors of Treatment for Hepatitis C Virus (HCV) Infection in Drug Users
    Reed, Carrie
    Stuver, Sherri O.
    Tumilty, Sheila
    Nunes, David
    Murray, Jessica E.
    Graham, Camilla S.
    Koziel, Margaret James
    Craven, Donald E.
    Skolnik, Paul R.
    Horsburgh, C. Robert, Jr.
    SUBSTANCE ABUSE, 2008, 29 (01) : 5 - 15
  • [27] Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals
    Hopkins, S
    Lambourne, J
    Farrell, G
    McCullagh, L
    Hennessy, M
    Clarke, S
    Mulcahy, F
    Bergin, C
    HIV MEDICINE, 2006, 7 (04) : 248 - 254
  • [28] Real-world challenges for hepatitis C virus medications: a critical overview
    Shahid, Imran
    AlMalki, Waleed Hassan
    Hassan, Sajida
    Hafeez, Muhammad Hassan
    CRITICAL REVIEWS IN MICROBIOLOGY, 2018, 44 (02) : 143 - 160
  • [29] REAL-WORLD STUDY OF HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS IN PATIENTS WITH DRUG ABUSE AND OPIOID AGONIST THERAPY
    Gayam, Vijay
    Tiongosn, Benjamin
    Mandal, Amrendra
    Garlapati, Pavani
    Gill, Arshpal
    Mohanty, Smruti
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (04) : 786 - 787
  • [30] Real-world study of hepatitis C treatment with direct-acting antivirals in patients with drug abuse and opioid agonist therapy
    Gayam, Vijay
    Tiongson, Benjamin
    Mandal, Amrendra Kumar
    Garlapati, Pavani
    Pan, Calvin
    Mohanty, Smruti
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (05) : 646 - 655
12345